Sign in
4

Changes in Ownership

ALNYLAM PHARMACEUTICALS, INC. Filed Acc 0001735276-25-000002

Director sold 11,250 shares at $275.00 ($3,093,750)

  • Director acquired 11,250 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

SHARP PHILLIP A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-23 Exercise or conversion : show line 1 in the form 10b5-1 +11,250 $131.21 $1,476,113 11,250 D
2025-01-23 Sale : show line 2 in the form 10b5-1 −11,250 $275.00 $3,093,750 0 D
Open-market sales · 11,250 sh · avg $275.00 · $3,093,750

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-23 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −11,250 0 D
Loading xslF345X05/edgardoc.xml…